Top Markets
#1 Siren Siren +33.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.97%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.33%
#4 Wiki Cat Wiki Cat +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.44%
#7 Cysic Cysic +16.42%
#8 Bitway Bitway +16.08%
#9 KUB Coin KUB Coin +15.73%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.35%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classificação em ações #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preço da ação
$0.39
Valor de mercado
$13.79M
Variação (1 dia)
-13.53%
Variação (1 ano)
-68.80%
País
IL
Negociar NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Healthcare
Lucros da NeuroSense Therapeutics Ltd. (NRSN)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da NeuroSense Therapeutics Ltd., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da NeuroSense Therapeutics Ltd. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE